Takeda seeks cetilistat Japanese approval

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) submitted an NDA to Japan's

Read the full 109 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE